LQDA Q2 2024 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-23.5% YoY

Gross Profit

$2M59.2% margin

Operating Income

-$27M-743.3% margin

Net Income

-$28M-763.7% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+23.1%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$24M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$177M

Total Liabilities

$115M

Stockholders' Equity

$63M

Cash & Equivalents

$133M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$5M	-23.5%
Gross Profit	$2M	$4M	-47.4%
Operating Income	-$27M	-$23M	-19.2%
Net Income	-$28M	-$24M	-18.8%